1. Burden and cost of hospital admissions for vaccine-preventable paediatric pneumococcal disease and non-typable Haemophilus influenzae otitis media in New Zealand

   • Richard J. Milne
   • Stephen Vander Hoorn

   Original Research Article 06 August 2012 Pages: 281 - 300

   

2. Global spending on orphan drugs in France, Germany, the UK, Italy and Spain during 2007

   • Javier Orofino
   • Javier Soto
   • Itziar Oyagüez

   Original Research Article 06 August 2012 Pages: 301 - 315

   

3. Cost of illness and drivers of cost in atrial fibrillation in Sweden and Germany

   • Linus Jönsson
   • Åsa Eliasson
   • Nils Edvardsson

   Original Research Article 06 August 2012 Pages: 317 - 325

   

4. Cost effectiveness of long-acting risperidone in Sweden

   • Marja Hensen
   • Bart Heeg
   • Ben van Hout

   Original Research Article 06 August 2012 Pages: 327 - 341

   

5. Issues surrounding orphan disease and orphan drug policies in Europe

   • Alain Denis
   • Lut Mergaert
   • Steven Simoens

   Current Opinion 06 August 2012 Pages: 343 - 350

6. Economic efficiency of alcohol policy

   • Christopher M. Doran
   • Thameemul A. Jainullabudeen

   Editorial Open access 06 August 2012 Pages: 351 - 354